Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BMB-101 in Prader-Willi Syndrome
NCT07266324Phase 2Not yet recruiting
- Sponsor
- Bright Minds Biosciences Inc.
- Start
- Jan 2026
- Primary completion
- Nov 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of BMB-101 in Prader-Willi syndrome (PWS), sponsored by Bright Minds Biosciences Inc.. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
BMB-101
03
Conditions
Prader-Willi syndrome (PWS)
Beyond the preview
Go deeper on NCT07266324.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07266324.